Literature DB >> 2362658

Treatment of carotid-cavernous fistulas associated with Ehlers-Danlos syndrome.

V V Halbach1, R T Higashida, C F Dowd, S L Barnwell, G B Hieshima.   

Abstract

Four patients with Ehlers-Danlos syndrome presented spontaneously with symptomatic direct carotid-cavernous fistulas. Two had previously (2 and 15 years, respectively) had contralateral carotid-cavernous fistulas that were treated with carotid occlusion procedures. The patients' ages at presentation ranged from 19 to 49 years, with a mean of 32 years. All four patients underwent attempted embolization procedures. Two patients had transarterial embolization, one with balloons and liquid adhesives, one with platinum coils and a balloon; the carotid artery was preserved in one and sacrificed in one other. In one patient, who underwent direct puncture of the carotid artery, a massive hematoma causing airway compromise required intubation and emergent surgical repair. The fistula spontaneously closed during this event. In the fourth patient, two transvenous embolizations resulted in markedly decreased flow, but diversion of residual flow to cortical veins produced a fatal pontine hemorrhage. The vascular fragility associated with Ehlers-Danlos syndrome can produce spontaneous direct carotid-cavernous fistulas and makes both diagnostic and therapeutic procedures more difficult.

Entities:  

Mesh:

Year:  1990        PMID: 2362658     DOI: 10.1097/00006123-199006000-00017

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  16 in total

1.  Treatment of carotid cavernous fistulas.

Authors:  Joseph J Gemmete; Neeraj Chaudhary; Aditya Pandey; Sameer Ansari
Journal:  Curr Treat Options Neurol       Date:  2010-01       Impact factor: 3.598

Review 2.  Ehlers-Danlos syndrome type IV and recurrent carotid-cavernous fistula: review of the literature, endovascular approach, technique and difficulties.

Authors:  H A Desal; F Toulgoat; S Raoul; B Guillon; S Bommard; E Naudou-Giron; E Auffray-Calvier; A de Kersaint-Gilly
Journal:  Neuroradiology       Date:  2005-04-06       Impact factor: 2.804

3.  A novel approach to the treatment of a direct carotid-cavernous fistula in a patient with Ehlers-Danlos syndrome type IV.

Authors:  Ichiro Nakagawa; Hun Soo Park; Takeshi Wada; Katsutoshi Takayama; Hiroyuki Nakagawa; Kimihiko Kichikawa; Hiroyuki Nakase
Journal:  BMJ Case Rep       Date:  2014-11-24

Review 4.  Ehlers-Danlos syndrome with a spontaneous caroticocavernous fistula occluded by detachable balloon: case report and review of literature.

Authors:  P Forlodou; A de Kersaint-Gilly; J Pizzanelli; M P Viarouge; E Auffray-Calvier
Journal:  Neuroradiology       Date:  1996-08       Impact factor: 2.804

5.  Endovascular treatment of direct carotid cavernous fistulae: a pictorial review.

Authors:  Arun K Gupta; Sukalyan Purkayastha; T Krishnamoorthy; Narendra K Bodhey; T R Kapilamoorthy; C Kesavadas; Bejoy Thomas
Journal:  Neuroradiology       Date:  2006-09-13       Impact factor: 2.804

6.  Direct cervical arterial access for intracranial endovascular treatment.

Authors:  R Blanc; M Piotin; C Mounayer; L Spelle; J Moret
Journal:  Neuroradiology       Date:  2006-12       Impact factor: 2.804

Review 7.  Ehlers-Danlos syndrome and neurological features: a review.

Authors:  Salvatore Savasta; Pietro Merli; Martino Ruggieri; Lucia Bianchi; Maria Valentina Spartà
Journal:  Childs Nerv Syst       Date:  2010-08-10       Impact factor: 1.475

8.  Myelopathy due to large veins draining recurrent spontaneous caroticocavernous fistula.

Authors:  Y Narita; Y Watanabe; T Hoshino; M Okada; Y Yamamoto; S Kuzuhara
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

9.  Cerebrovascular Involvement in Ehlers-Danlos Syndrome.

Authors:  Wouter I. Schievink
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

Review 10.  Neurovascular manifestations of connective-tissue diseases: A review.

Authors:  Sarasa T Kim; Waleed Brinjikji; Giuseppe Lanzino; David F Kallmes
Journal:  Interv Neuroradiol       Date:  2016-08-10       Impact factor: 1.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.